Careful patient selection together with optimal implant positioning may reduce but does not eliminate the risk of elevated serum cobalt and chrome levels following metal-on-metal hip resurfacing.

MLA

Oxblom, Alexander, et al. “Careful Patient Selection Together with Optimal Implant Positioning May Reduce but Does Not Eliminate the Risk of Elevated Serum Cobalt and Chrome Levels Following Metal-on-Metal Hip Resurfacing.” Hip International, vol. 33, no. 5, Sept. 2023, pp. 872–79. EBSCOhost, https://doi.org/10.1177/11207000221124302.

APA

Oxblom, A., Hedlund, H., Itayem, R., Felländer-Tsai, L., Vidgren, M., Rolfson, O., & Brismar, H. (2023). Careful patient selection together with optimal implant positioning may reduce but does not eliminate the risk of elevated serum cobalt and chrome levels following metal-on-metal hip resurfacing. Hip International, 33(5), 872–879. https://doi.org/10.1177/11207000221124302

Chicago

Oxblom, Alexander, Håkan Hedlund, Raed Itayem, Li Felländer-Tsai, Mathias Vidgren, Ola Rolfson, and Harald Brismar. 2023. “Careful Patient Selection Together with Optimal Implant Positioning May Reduce but Does Not Eliminate the Risk of Elevated Serum Cobalt and Chrome Levels Following Metal-on-Metal Hip Resurfacing.” Hip International 33 (5): 872–79. doi:10.1177/11207000221124302.